Belluscura PLC said late Thursday that it will raise 5 million pounds ($6.1 million) via a share placing to fund costs relating to a manufacturing agreement with InnoMax Medical Technology Ltd.

The London-listed developer of medical devices the number of placing shares, as well as their issue price, will be determined at the end of the bookbuild.

"Following the successful completion of the placing, the company and InnoMax intend to execute statements of work, which will specify the terms and conditions by which InnoMax will assist the company in the design, manufacture, assembly, repair and/or distribution of the X-PLO2R portable oxygen concentrator family of products at InnoMax's production facility in Shenzhen," the company said.

Write to Anthony O. Goriainoff at anthony.orunagoriainoff@dowjones.com

The market climbed Friday, but concerns around Fed policy linger.

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More.